Welcome to Our Parkinson's Place

I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please No advertisers, and No Information about Herbal treatments. Please no advertisements.
This is a free site for all.
Thank you.

Friday, March 31, 2017

UNMC Parkinson's Therapy Potentially a Breakthrough

March 31, 2017    

Parkinson’s disease affects nearly one million Americans and costs around 25 billion dollars a year in the United States alone.  It’s a progressive neurodegenerative disease for which there is currently no cure, but a UNMC research team has evidence their new drug therapy can bring about improvements in patients with Parkinson’s.
The research team is led by Drs. Howard Gendelman and R. Lee Mosley, both Professors of Pharmacology and Experimental Neuroscience at UNMC. Their drug regimen changes disease-causing white blood cells into cells that protect and defend against brain injury. 
Gendelman calls their therapy a breakthrough in Parkinson’s treatment.
“If we can train or augment the immune system to alter the microenvironment – the injurious microenvironment of the brain, we can then shift a toxic setting, or a toxic environment for Parkinson’s disease, into something that will elicit repair and regeneration of specific nerve cells that are damaged or even dying during the disease process.”
Gendelman says the next step will involve clinical trials with larger numbers of patients, which should happen within the next one to two years. 
For more information on the study, the website is

No comments:

Post a Comment